Erythropoiesis-stimulating agents for preventing acute kidney injury

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

This review aims to look at the benefits and harms of ESAs for preventing AKI in the context of any health condition.

This is a protocol.

Published:

4 May 2022

Authors:

Nishiwaki H, Abe Y, Hasegawa T, Levack WMM, Noma H, Ota E

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Nishiwaki H, AbeY, HasegawaT, LevackWMM, NomaH, OtaE.Erythropoiesis-stimulating agents for preventing acute kidney injury (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD014820. DOI: 10.1002/14651858.CD014820.